Photo taken from: Ivana Cattaneo/LinkedIn
Mar 18, 2024, 23:27
Ivana Cattaneo: One week ago five new global teams have been selected to receive up to $25m each over five years to tackle some of cancer’s toughest challenges
Ivana Cattaneo, Executive Director Therapeutic Area Advocacy and Precision Medicine at Novartis, shared the following on LinkedIn:
“One week ago five new global teams have been selected to receive up to $25m each over five years to tackle some of cancer’s toughest challenges: Cancer inequities, Early-onset cancers, Solid tumours in children and T-cell receptors.
Here the five new teams and here (some of) the advocacy panel experts I have the pleasure to work with in Cancer Grand Challenges.
Yelak Biru, Joya Delgado Harris, Dirk Hellrung (credit to Patrick Harrison for the picture and to Andrea Delgado Garcia for the leadership in steering our work).”
Source: Ivana Cattaneo/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 23:35
Nov 13, 2024, 23:33
Nov 13, 2024, 23:28
Nov 13, 2024, 23:26
Nov 13, 2024, 23:22
Nov 13, 2024, 23:18
Nov 13, 2024, 19:25